Clinical Trial Detail

NCT ID NCT02634827
Title Midostaurin and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia and FLT3 Mutation
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Mayo Clinic
Indications

acute myeloid leukemia

Therapies

Decitabine + Midostaurin

Age Groups: senior

Additional content available in CKB BOOST